银梅溃结汤通过抑制花生四烯酸代谢缓解溃疡性结肠炎的多组学研究
该研究结合多组学、网络药理学与实验验证,探讨银梅溃结汤(YMKJD)治疗溃疡性结肠炎(UC)的疗效与机制。结果表明YMKJD可改善DSS诱导小鼠UC症状、减轻肠上皮屏障破坏,并通过下调COX-2、5-LOX、PTGES抑制花生四烯酸代谢及PI3K/AKT信号,减少促炎介质与ROS,阻断巨噬细胞M1极化。
要点
- YMKJD可改善UC小鼠临床症状并减轻结肠组织损伤。
- YMKJD下调COX-2、5-LOX、PTGES,抑制花生四烯酸代谢。
- YMKJD阻断COX-2驱动的巨噬细胞M1极化并降低ROS。
核心结论
- YMKJD通过抑制花生四烯酸代谢及PI3K/AKT信号,减轻UC炎症与肠上皮屏障破坏。
- 花生四烯酸代谢激活可抵消YMKJD在动物和细胞UC模型中的保护作用。
研究设计与样本
- 采用DSS诱导小鼠UC模型、TNF-α处理Caco-2细胞、LPS刺激RAW264.7巨噬细胞及结肠类器官进行体内外研究。
- 整合非靶向代谢组学、转录组测序与网络药理学,并用qRT-PCR和Western blot验证候选靶点。
主要发现
- YMKJD显著改善UC小鼠临床症状并减轻结肠组织损伤。
- YMKJD在体内外减轻肠上皮屏障破坏。
- YMKJD下调COX-2、5-LOX、PTGES,抑制白三烯B4、前列腺素E2及ROS等促炎介质。
- YMKJD抑制炎症上皮细胞中PI3K/AKT信号。
- YMKJD阻断COX-2驱动的巨噬细胞M1极化,降低共培养结肠类器官ROS水平。
临床怎么用
- YMKJD可能作为UC的新型治疗策略,其机制涉及抑制花生四烯酸代谢与巨噬细胞M1极化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Yinmeikuijie decoction (YMKJD), a traditional Chinese herbal formulation, has demonstrated clinical efficacy in alleviating ulcerative colitis (UC). However, its underlying therapeutic mechanisms remain poorly understood. AIM OF THE STUDY: We aimed to assess the therapeutic efficacy of YMKJD against UC and to unravel its underlying mechanisms through both in vivo and in vitro investigations. MATERIALS AND METHODS: Dextran sulfate sodium (DSS)-induced murine UC model mice, TNF-α-treated Caco-2 cells, LPS-stimulated RAW264.7 macrophages, and colon organoids were utilized to investigate YMKJD's therapeutic effects. Macrophage polarization (M1/M2 subsets) was assessed via flow cytometry and immunofluorescence. Immunofluorescence staining and Western blot were performed to evaluate the intestinal epithelial barrier (IEB). Untargeted metabolomics, transcriptomic sequencing, and network pharmacology were integrated to elucidate key pathways. Candidate targets were further verified using qRT‒PCR and Western blot. RESULTS: YMKJD administration markedly improved clinical symptoms and mitigated colonic tissue damage in UC mice. YMKJD attenuated IEB disruption in vivo and in vitro. Mechanistically, combined bioinformatics and experimental analyses revealed that YMKJD downregulated the expression of the key enzymes (COX-2, 5-LOX, PTGES) in the arachidonic acid (AA) metabolism, thereby suppressing proinflammatory mediators (Leukotriene B4, Prostaglandin E2, ROS) and inhibiting PI3K/AKT signaling in inflamed epithelial cells. Interestingly, YMKJD also blocked COX-2-driven M1 polarization in macrophages, diminishing ROS levels in cocultured colon organoids. Rescue studies confirmed that AA metabolism activation counteracted YMKJD's protective effects in both animal and cellular UC models. CONCLUSIONS: Our findings demonstrate YMKJD's therapeutic potential and its mechanism in UC, suggesting its utility as a novel treatment strategy.
引用
- Liu Y, Gu Y, Zhu W, et al. Integrated multi-omics, network pharmacology, and experimental validation reveal that Yinmeikuijie decoction alleviates ulcerative colitis by inhibiting arachidonic acid metabolism. J Ethnopharmacol. 2025. PMID: 41241212. doi:10.1016/j.jep.2025.120892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。